GD
GD6.F Ramsay Générale de Santé SA
- Market cap
- EUR 932M
- P/E
- -
- P/B
- 0.85x
- ROE
- -4.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is GD6.F undervalued?
Graham numberThe Graham number of Ramsay Générale de Santé SA cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ramsay Générale de Santé SA fundamental analysis
No fundamental analysis for Ramsay Générale de Santé SA yet.
Ramsay Générale de Santé SA stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ramsay Générale de Santé SA
Ramsay Générale de Santé SA operates healthcare facilities in France, Sweden, Norway, Denmark, and Italy. It provides preventive care, primary medicine, medicine surgery obstetrics, oncology, medical imaging, medical care and rehabilitation, home hospitalization, mental health care and addiction treatment, geriatrics, tele monitoring and e health services; and operates medical centres, and mental health day care centres. The company was formerly known as Générale de Santé SA…
Full company profileRamsay Générale de Santé SA financial statements
Ramsay Générale de Santé SA annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 2.23B | 2.24B | 3.40B | 3.75B | 4.02B | 4.30B | 4.70B | 5.01B | 5.21B | 5.38B |
| Gross Profit | 1.79B | 1.79B | 2.76B | 3.01B | 3.20B | 3.41B | 3.72B | 3.94B | 4.08B | 4.23B |
| Operating Income | 133M | 126M | 157M | 185M | 259M | 293M | 220M | 184M | 186M | 191M |
| EBITDA | 263M | 188M | 285M | 534M | 610M | 678M | 646M | 563M | 596M | 602M |
| Net Income | 57.0M | 7.30M | 8.20M | 13.4M | 65.0M | 118M | 49.4M | -53.9M | -54.1M | -48.3M |
| EPS | 0.70 | 0.09 | 0.07 | 0.12 | 0.59 | 1.07 | 0.45 | -0.49 | -0.49 | -0.44 |
| Balance Sheet | ||||||||||
| Total Assets | 2.35B | 2.50B | 4.36B | 6.71B | 6.68B | 6.79B | 6.96B | 6.90B | 6.84B | 6.68B |
| Total Liabilities | 1.84B | 1.99B | 3.32B | 5.68B | 5.58B | 5.55B | 5.68B | 5.67B | 5.66B | 5.53B |
| Shareholders' Equity | 462M | 470M | 996M | 1.01B | 1.07B | 1.21B | 1.25B | 1.19B | 1.15B | 1.12B |
| Cash & Short-term Investments | 181M | 308M | 369M | 538M | 608M | 133M | 352M | 359M | 367M | 302M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 209M | 214M | 214M | 730M | 652M | 263M | 599M | 587M | 694M | 525M |
| Capital Expenditure | 102M | 62.6M | 178M | 169M | 176M | 194M | 172M | 169M | 143M | 144M |
| Free Cash Flow | 107M | 151M | 35.6M | 561M | 476M | 68.9M | 427M | 418M | 551M | 381M |
| Ratios | ||||||||||
| ROE | 12.3% | 1.6% | 0.8% | 1.3% | 6.1% | 9.8% | 4.0% | -4.5% | -4.7% | -4.3% |
| ROA | 2.4% | 0.3% | 0.2% | 0.2% | 1.0% | 1.7% | 0.7% | -0.8% | -0.8% | -0.7% |
| Net Profit Margin | 2.6% | 0.3% | 0.2% | 0.4% | 1.6% | 2.8% | 1.1% | -1.1% | -1.0% | -0.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Ramsay Générale de Santé SA dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Dec 2, 2014
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | EUR 4.80M | 0.06 | 8.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Ramsay Générale de Santé SA
- Insiders 59.47%
- Institutions 39.92%
- Public & others 0.61%
- Shares outstanding 110M
- Free float 768K
Ramsay Générale de Santé SA company profile
- Company name
- Ramsay Générale de Santé SA
- Ticker
- GD6.F
- ISIN
- FR0000044471
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 40,597
- Fiscal year end
- June
- Address
- Immeuble REIWA, Saint-Ouen-sur-Seine, France, 93400
- Phone
- 33 1 87 86 21 52
- Website
- ramsaygds.fr
About Ramsay Générale de Santé SA
Ramsay Générale de Santé SA operates healthcare facilities in France, Sweden, Norway, Denmark, and Italy. It provides preventive care, primary medicine, medicine surgery obstetrics, oncology, medical imaging, medical care and rehabilitation, home hospitalization, mental health care and addiction treatment, geriatrics, tele monitoring and e health services; and operates medical centres, and mental health day care centres. The company was formerly known as Générale de Santé SA and changed its name to Ramsay Générale de Santé SA in December 2015. The company was founded in 1987 and is headquartered in Saint-Ouen-sur-Seine, France. Ramsay Générale de Santé SA operates as a subsidiary of Ramsay Health Care Limited.
Ramsay Générale de Santé SA management
10- Mr. Pascal RocheChief Executive Officer · born 1962
- Mr. Clement LafaixGroup Chief Financial Officer
- Mr. Pierre DuperatDirector of Group Investments and Risks · born 1969
- Ms. Isabelle MetrefHead of Investor Relations
- Ms. Laurence Pinot-LacanGroup Legal Director & Secretary of the Board of Director
- Mr. Henrik BrehmerGroup Director of Strategy & Public Affairs · born 1964
- Ms. Brigitte CachonGroup Impact & Sustainability Director
- Mr. Jerome BriceManaging Director of France
- Ms. Margareta DaneliusChief Medical Officer · born 1964
- Maria ArnouxChief of Staff to Pascal Roché